| Study |
Reference |
|
Agosti, 2015
|
Agosti M Long-Term Follow-Up of Children Born to Mothers with Chronic Arthritides and Exposed in Utero to Anti-TNF-Alpha Agents: A Case-Control Study Ann Rheum Dis 2015;74(Suppl 2):709–710
|
|
Broms (Controls exposed to other treatments), 2020
|
Broms Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden. Pharmacoepidemiol Drug Saf 2020; 29:316-327
|
|
Broms (Controls unexposed, disease free), 2020
|
Broms Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden. Pharmacoepidemiol Drug Saf 2020; 29:316-327
|
|
Bröms a (Controls unexposed, disease free), 2016
|
Bröms G Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti-Tumor Necrosis Factor Agents During Pregnancy Clin Gastroenterol Hepatol. 2016a;14(2):234-241
|
|
Bröms a (Controls unexposed, sick), 2016
|
Bröms G Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti-Tumor Necrosis Factor Agents During Pregnancy Clin Gastroenterol Hepatol. 2016a;14(2):234-241
|
|
Bröms b, 2016
|
Broms G Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment. Scand J Gastroenterol 2016;51:1462-1469
|
|
Carman - Etanercept (Controls unexposed, disease free), 2017
|
Carman WJ Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use. Pharmacoepidemiol Drug Saf 2017;26:1109-1118
|
|
Carman - Etanercept (Controls unexposed, sick), 2017
|
Carman WJ Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use. Pharmacoepidemiol Drug Saf 2017;26:1109-1118
|
|
Casanova, 2013
|
Casanova MJ Safety of thiopurines and anti-TNF-? drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol 2013;108:433-40
|
|
Chambers - Adalimumab (Controls unexposed, disease free), 2017
|
Chambers CD Birth Outcomes Following Pregnancy Exposure to Adalimumab: The OTIS Autoimmune Diseases in Pregnancy Project Pharmacoepidemiology and Drug Safety 2017;26:218–219
|
|
Chambers - Adalimumab (Controls unexposed, sick, ADA only), 2017
|
Chambers CD Birth Outcomes Following Pregnancy Exposure to Adalimumab: The OTIS Autoimmune Diseases in Pregnancy Project Pharmacoepidemiology and Drug Safety 2017;26:218–219
|
|
Chambers - Etanercept, 2015
|
Chambers Pregnancy Outcome in Women Treated with Etanercept: An Update on the OTIS Autoimmune Diseases in Pregnancy Project Pharmacoepidemiology and Drug Safety 2015; 24:402–402
|
|
Chaparro, 2018
|
Chaparro M Long-Term Safety of In Utero Exposure to Anti-TNF? Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. Am J Gastroenterol 2018;113:396-403
|
|
Cooper, 2014
|
Cooper Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy. 2014; 66:444-50
|
|
De Lima, 2018
|
de Lima A Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero. J Crohns Colitis 2018;12:948-953
|
|
De Lima (Controls unexposed, disease free), 2016
|
de Lima A Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety. Gut 2016;65:1261-8
|
|
De Lima (Treatment stopped during pregnancy, sick), 2016
|
de Lima A Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety. Gut 2016;65:1261-8
|
|
De Lorenzo (Controls unexposed, disease free), 2020
|
De Lorenzo Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives. Pharmacol. Res. 2020; 152:104583
|
|
De Lorenzo (Controls unexposed, sick), 2020
|
De Lorenzo Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives. Pharmacol. Res. 2020; 152:104583
|
|
Desai, 2017
|
Desai RJ Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ 2017;356:j895
|
|
Diav-Citrin (Controls exposed to other treatments), 2014
|
Diav-Citrin O Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. Reprod Toxicol 2014;43:78-84
|
|
Diav-Citrin (Controls unexposed, disease free), 2014
|
Diav-Citrin O Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. Reprod Toxicol 2014;43:78-84
|
|
Drechsel, 2020
|
Drechsel Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a JIA biologic registry. Rheumatology (Oxford) 2020; 59:603-612
|
|
Duricova, 2019
|
Duricova Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation. Inflamm. Bowel Dis. 2019; 25:789-796
|
|
Fu - Etanercept, 2019
|
Fu A randomized controlled trial of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders. Taiwan J Obstet Gynecol 2019; 58:621-625
|
|
Hoxha, 2017
|
Hoxha A Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study. Joint Bone Spine 2017;84:169-173
|
|
Komoto, 2016
|
Komoto Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan. Intest Res 2016; 14:139-45
|
|
Langen, 2014
|
Langen High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol 2014; 31:9-14
|
|
Lichtenstein - infliximab, 2018
|
Lichtenstein GR Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report. Am J Gastroenterol 2018;113:1678-1688
|
|
Luu, 2018
|
Luu M Continuous Anti-TNF? Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION). Am J Gastroenterol 2018;113:1669-1677
|
|
Moens (Controls exposed to Vedolizumab), 2020
|
Moens Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Aliment. Pharmacol. Ther. 2020; 51:129-138
|
|
Moens (Controls unexposed, sick), 2020
|
Moens Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Aliment. Pharmacol. Ther. 2020; 51:129-138
|
|
Schnitzler (Controls unexposed, disease free), 2011
|
Schnitzler F Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis 2011;17:1846-54
|
|
Schnitzler (Unexposed control, sick), 2011
|
Schnitzler F Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis 2011;17:1846-54
|
|
Seirafi, 2014
|
Seirafi M Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease. Aliment Pharmacol Ther 2014;40:363-73
|
|
Verstappen, 2011
|
Verstappen SM Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011;70:823-6
|
|
Viktil (Controls exposed to other treatments), 2012
|
Viktil Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41:196-201
|
|
Viktil (Controls unexposed, NOS), 2012
|
Viktil Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41:196-201
|
|
Vinet, 2013
|
Vinet E Induced abortions in women with rheumatoid arthritis receiving methotrexate. Arthritis Care Res (Hoboken) 2013;65:1365-9
|
|
Vinet (Controls unexposed, disease free), 2018
|
Vinet E Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study. Arthritis Rheumatol 2018;70:1565-1571
|
|
Vinet (Controls unexposed, sick), 2018
|
Vinet E Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study. Arthritis Rheumatol 2018;70:1565-1571
|
|
Weber-Schoendorfer, 2015
|
Weber-Schoendorfer C Pregnancy outcome after TNF-? inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br J Clin Pharmacol 2015;80:727-39
|
|
Zbinden (rheumatoid arthritis), 2018
|
Zbinden Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology (Oxford) 2018; 57:1235-1242
|
|
Zbinden b (axial spondyloarthritis), 2018
|
Zbinden Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology (Oxford) 2018; 57:1235-1242
|
